Market Dynamics:
The growing prevalence of neurological disorders has been a key driver for the neurological biomarkers market. According to World Health Organization estimates, over 1 billion people globally suffer from neurological disorders with Alzheimer's disease and other dementias affecting over 55 million people worldwide. Such high disease prevalence has created significant need for...
0 Commentarios
0 Acciones
1039 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian